Life ScienceCompany
Disarm Therapeutics Ownership
Who owns Disarm Therapeutics?
Disarm Therapeutics is owned by Eli Lilly. It was acquired on October 15, 2020.
Disarm Therapeutics Business Overview
Where is Disarm Therapeutics headquartered?
Disarm Therapeutics is headquartered in Cambridge, Massachusetts.
What sector is Disarm Therapeutics in?
Disarm Therapeutics is a life science company.
Life Science M&A Summary in 2020
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.
Join Mergr to view all 290 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 267 by strategics.